Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H8N2O8S2.2Na |
| Molecular Weight | 466.353 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].[O-]S(=O)(=O)C1=CC=C2N\C(C(=O)C2=C1)=C3\NC4=C(C=C(C=C4)S([O-])(=O)=O)C3=O
InChI
InChIKey=KHLVKKOJDHCJMG-QDBORUFSSA-L
InChI=1S/C16H10N2O8S2.2Na/c19-15-9-5-7(27(21,22)23)1-3-11(9)17-13(15)14-16(20)10-6-8(28(24,25)26)2-4-12(10)18-14;;/h1-6,17-18H,(H,21,22,23)(H,24,25,26);;/q;2*+1/p-2/b14-13+;;
| Molecular Formula | Na |
| Molecular Weight | 22.98976928 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C16H8N2O8S2 |
| Molecular Weight | 420.373 |
| Charge | -2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Indigotindisulfonic acid (also known as Indigo carmine) is a synthetic dye discovered in 18th century. It is used in many countiries as a food colorant and a pH indicator. In medicine the dye is used to localize ureteral orifices during cystoscopy and ureteral catheterization. In June 2014 the FDA announced the shortage of indigotindisulfonic acid.
CNS Activity
Originator
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
80 mg single, intravenous Higher than recommended Dose: 80 mg Route: intravenous Route: single Dose: 80 mg Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: F Food Status: UNKNOWN Sources: |
Other AEs: Hypertension... |
40 mg single, intravenous Recommended Dose: 40 mg Route: intravenous Route: single Dose: 40 mg Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M Food Status: UNKNOWN Sources: |
Other AEs: Hypotension, Bronchospasm... Other AEs: Hypotension (grade 3) Sources: Bronchospasm (grade 3) Urticaria (grade 3) |
40 mg single, intravenous Recommended Dose: 40 mg Route: intravenous Route: single Dose: 40 mg Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
Other AEs: Atrioventricular block... |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Hypertension | grade 3 | 80 mg single, intravenous Higher than recommended Dose: 80 mg Route: intravenous Route: single Dose: 80 mg Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: F Food Status: UNKNOWN Sources: |
| Bronchospasm | grade 3 | 40 mg single, intravenous Recommended Dose: 40 mg Route: intravenous Route: single Dose: 40 mg Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M Food Status: UNKNOWN Sources: |
| Hypotension | grade 3 | 40 mg single, intravenous Recommended Dose: 40 mg Route: intravenous Route: single Dose: 40 mg Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M Food Status: UNKNOWN Sources: |
| Urticaria | grade 3 | 40 mg single, intravenous Recommended Dose: 40 mg Route: intravenous Route: single Dose: 40 mg Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M Food Status: UNKNOWN Sources: |
| Atrioventricular block | 40 mg single, intravenous Recommended Dose: 40 mg Route: intravenous Route: single Dose: 40 mg Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
Drug as perpetrator
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
| no [IC50 >1000 uM] | ||||
| no [IC50 >1000 uM] | ||||
| no [IC50 >2000 uM] | ||||
| no [IC50 >2000 uM] | ||||
Page: 39.0 |
no | |||
| yes [IC50 50 uM] |
Drug as victim
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
| no | ||||
Page: 41 | 45 |
no | |||
| no | ||||
| no |
PubMed
| Title | Date | PubMed |
|---|---|---|
| The detection of sentinel lymph nodes in laparoscopic surgery for uterine cervical cancer using 99m-technetium-tin colloid, indocyanine green, and blue dye. | 2017-03 |
|
| A Third Surgically Managed Ectopic Pregnancy after Two Salpingectomies Involving the Opposite Tube. | 2017 |
|
| Clinical impact of dual red imaging in colorectal endoscopic submucosal dissection: a pilot study. | 2016-09 |
|
| TiO2 immobilized on Manihot carbon: optimal preparation and evaluation of its activity in the decomposition of indigo carmine. | 2015-01-12 |
|
| Microdochectomy assisted by ultrasound-guided indigo carmine staining of intraductal lesions: a case report. | 2014-06 |
|
| Case of Wenckebach-type atrioventricular block caused by administration of indigo carmine. | 2014-03-20 |
|
| High-definition vs. standard-definition endoscopy with indigo carmine for the in vivo diagnosis of colonic polyps. | 2013-12 |
|
| Profound hypotension after an intradermal injection of indigo carmine for sentinel node mapping. | 2013-03 |
|
| Extensive skin color change caused by extravasation of indigo carmine. | 2012-05 |
|
| The use of indigo carmine for dye dilution curves. | 1955-11 |
|
| REFINEMENT OF COLORIMETRIC METHODS WITH SPECIAL REFERENCE TO INDIGO CARMINE AS A FUNCTIONAL TEST: A PRELIMINARY REPORT. | 1920-02 |
Patents
Sample Use Guides
Indigotindisulfonic acid (Indigo Carmine) solution is injected either by the intravenous or intramuscular route, and its appearance at the ureteral orifices is watched with the cystoscope in place.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23341851
Human chondrocytes grown on 6-well plates to 80% subconfluence were incubated with different concentrations of indigotindisulfonic acid (1, 10 and 100% solution) for 5 and 10 minutes. Human chondrocytes treated with solutions of 100% solution showed increased number of cells with defect cell structure. Chondrocytes showed loss of cell contacts after an incubation time of 10 minutes as revealed by light microscopy.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:16:50 GMT 2025
by
admin
on
Mon Mar 31 18:16:50 GMT 2025
|
| Record UNII |
D3741U8K7L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Preferred Name | English | ||
|
Preferred Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CODEX ALIMENTARIUS (GSFA) |
INS-132
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
||
|
WHO-ATC |
V04CH02
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
||
|
WHO-VATC |
QV04CH02
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
||
|
NCI_THESAURUS |
C461
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
||
|
JECFA EVALUATION |
INS-132
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
D3741U8K7L
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY | |||
|
100000078725
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY | |||
|
CHEMBL1091250
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY | |||
|
SUB12518MIG
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY | |||
|
227312
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY | RxNorm | ||
|
5284351
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY | |||
|
m6252
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY | Merck Index | ||
|
INDIGO CARMINE
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY | |||
|
DBSALT001752
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY | |||
|
212-728-8
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY | |||
|
31695
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY | |||
|
DTXSID1020190
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY | |||
|
1339000
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY | |||
|
860-22-0
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY | |||
|
7875
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY | |||
|
D007203
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY | |||
|
SUB127375
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY | |||
|
4575
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY | |||
|
C83799
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY | |||
|
D3741U8K7L
Created by
admin on Mon Mar 31 18:16:50 GMT 2025 , Edited by admin on Mon Mar 31 18:16:50 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|